Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
University Hospital, Clermont-Ferrand |
---|---|
Information provided by: | University Hospital, Clermont-Ferrand |
ClinicalTrials.gov Identifier: | NCT00484549 |
Fabry disease is a genetic disease due to an enzymatic deficit. A screening of this disease allows patients to benefit from an enzyme replacement therapy and prevent the occurrence of life threatening manifestations such as an ischemic stroke.
The purpose of the study is to determinate the prevalence of Fabry disease in a population of male patients hospitalized for an ischemic stroke.
This study, with a screening of Fabry disease, allows the patients to make a precise diagnosis of their ischemic stroke and to facilitate the screening of the other members at the facility.
Condition | Intervention |
---|---|
Ischemic Stroke Hospitalized |
Procedure: Blood sample |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind (Subject), Active Control, Single Group Assignment, Efficacy Study |
Official Title: | National, Multicenter, Prospective Study of Screening of Fabry Disease in a Population of Men Over 28 Days Old and Less Than 55 Years, Hospitalized for an Ischemic Stroke. |
Estimated Enrollment: | 889 |
Study Start Date: | March 2007 |
Estimated Study Completion Date: | March 2009 |
Estimated Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | up to 55 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Pierre Clavelou, Pr | 04.73.75.22.01 | pclavelou@chu-clermontferrand.fr |
Contact: Dominique P Germain + Boucly, Pr | dominique.germain@rpc.aphp.fr |
France | |
Hôpital Gabriel Montpied | Recruiting |
Clermont-Ferrand, France, 63003 |
Principal Investigator: | Pierre Clavelou, Pr | Unaffilliated |
Responsible Party: | CHU Clermont-Ferrand ( Pierre CLAVELOU ) |
Study ID Numbers: | CHU63-0019 |
Study First Received: | June 8, 2007 |
Last Updated: | October 7, 2008 |
ClinicalTrials.gov Identifier: | NCT00484549 |
Health Authority: | France: Ministry of Health |
Fabry disease, Screening, Ischemic stroke |
Ceramide trihexosidosis Cerebral Infarction Stroke Fabry Disease Fabry disease |
Vascular Diseases Central Nervous System Diseases Ischemia Brain Diseases Cerebrovascular Disorders |
Pathologic Processes Nervous System Diseases Cardiovascular Diseases |